Anticoagulation in Atrial Fibrillation With Valvular Heart Disease

Anticoagulation in Atrial Fibrillation With Valvular Heart Disease

Saved in:

Bibliographic Details
Main Authors:	Ana Catarina Fonseca, Claúdia Jorge
Format:	Article
Language:	English
Published:	Wiley 2025-02-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	anticoagulants atrial fibrillation blood coagulation Editorials health services heart valve diseases
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.124.038736
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of the anticoagulant effect of vitamin K antagonists in patients with non-valvular atrial fibrilation
by: Stanojković Zoran, et al.
Published: (2020-01-01)

Direct Oral Anticoagulants Compared With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Without Mechanical Valves
by: Ghadeer K. Dawwas, et al.
Published: (2025-02-01)

Approaches to anticoagulation therapy selection in patients with non-valvular atrial fibrillation and ischemic heart disease
by: N. A. Koziolova, et al.
Published: (2016-04-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

Anticoagulation use in rheumatic heart disease-associated atrial fibrillation: a study of real-world practice in Central Australia
by: Sonia Sawant, et al.
Published: (2025-08-01)

Bleeding Risk Scores in Atrial Fibrillation: Helpful or Harmful?
by: Marissa K. Edmiston, et al.
Published: (2018-09-01)

HOW TO REDUCE GASTROINTESTINAL BLEEDING RISK ON ANTICOAGULATION THERAPY IN NON-VALVULAR ATRIAL FIBRILLATION?
by: E. I. Baranova, et al.
Published: (2017-11-01)

Oral anticoagulation in patients with hypertrophic cardiomyopathy and non‐valvular atrial fibrillation in Japan
by: Hiroaki Kitaoka, et al.
Published: (2025-02-01)

Anticoagulation Therapy for Atrial Fibrillation After Transcatheter Aortic Valve Replacement: National Database Insights
by: Koki Takegawa, et al.
Published: (2025-07-01)

Hypertension, chronic kidney disease, atrial fibrillation and the newer anticoagulants
by: B. Rayner
Published: (2012-10-01)

ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT
by: E. L. Dolgova, et al.
Published: (2015-09-01)

ATRIAL FIBRILLATION AND HEART FAILURE: APPROACHES TO ANTITHROMBOTIC THERAPY
by: B. A. Tatarsky, et al.
Published: (2017-08-01)

Stroke prevention for non-valvular atrial fibrillation: how to make the right choice of directly acting oral anticoagulants?
by: N. N. Kryukov, et al.
Published: (2019-02-01)

Inappropriate dosing of direct oral anticoagulants among very older inpatients with atrial fibrillation
by: Ya-Tong Zhang, et al.
Published: (2025-04-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)

Impact of shared decision-making in Taiwanese patients with atrial fibrillation eligible for novel oral anticoagulant therapy
by: Yen-Wen Wu, et al.
Published: (2025-03-01)

Rivaroxaban in stroke prevention in patients with non-valvular atrial fibrillation: what facts are important for the clinician?
by: I. S. Yavelov
Published: (2025-08-01)

Silent Cerebral İnfarction in Anticoagulated Patients with Non-valvular Atrial Fibrillation as Detected with Neuron Specific Enolase
by: Hüseyin Göksülük, et al.
Published: (2018-08-01)

A patient with atrial fibrillation and diabetes: selecting the optimal anticoagulant therapy regimen
by: A. G. Obrezan, et al.
Published: (2021-06-01)

Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice
by: Yu. P. Skirdenko, et al.
Published: (2022-03-01)

FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW
by: S. A. Zenin, et al.
Published: (2015-09-01)

Anticoagulation for Stroke Prevention in Patients with Atrial Fibrillation: A Review of the Literature and Current Guidelines
by: Vrinda Vyas, et al.
Published: (2025-06-01)

Anticoagulant and disease-modifying therapy for atrial fibrillation and heart failure in certain Russian regions in 2023
by: M. A. Druzhilov, et al.
Published: (2025-05-01)

Non-adherence and non-persistence of Direct Oral Anticoagulants among patients with non-valvular atrial fibrillation: a French retrospective cohort study
by: Victoria A. Fuchs, et al.
Published: (2025-03-01)

Clinical characteristics and frequency of anticoagulation in patients with atrial fibrillation and heart failure: results of a retrospective big data analysis
by: M. A. Druzhilov, et al.
Published: (2023-03-01)

Non-vitamin K antagonist oral anticoagulants (NOACs) in cancer patients with atrial fibrillation
by: Anetta Undas, et al.
Published: (2019-12-01)

Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
by: M. V. Serova, et al.
Published: (2021-09-01)

PHARMACODYNAMICS OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ACUTE PERIOD OF ISCHEMIC STROKE
by: V. I. Petrov, et al.
Published: (2021-01-01)

ANALYSIS OF THE FREQUENCY OF USING VARIOUS ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN REAL PRACTICE
by: A. N. Atakanova, et al.
Published: (2017-12-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01)

Factors determining adherence to anticoagulant therapy in patients with atrial fibrillation
by: D. V. Pevzner, et al.
Published: (2023-06-01)

Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF
by: Linda S. Johnson, et al.
Published: (2024-09-01)

Role of miRNA in the development of atrial fibrillation in patients with valvular heart disease
by: I. V. Abdulyanov, et al.
Published: (2020-11-01)

Prognosis of the influence of direct oral anticoagulants on the direct medical expenses in patients with atrial fibrillation
by: S. V. Malchikova, et al.
Published: (2020-08-01)

ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES
by: Z. M. Safiullina, et al.
Published: (2015-09-01)

ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION?
by: D. A. Napalkov, et al.
Published: (2016-05-01)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
by: Paula Tiili, et al.
Published: (2021-01-01)

Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2019-03-01)

New safety standards for anticoagulant therapy in the treatment of atrial fibrillation
by: E. I. Baranova
Published: (2018-11-01)

Clinical and pathogenetic characteristics and management of patients with atrial fibrillation in a cardiology department at the present time
by: V. K. Kurashin, et al.
Published: (2020-07-01)